Cargando…
Antibody-Based Therapeutic Interventions for Amyotrophic Lateral Sclerosis: A Systematic Literature Review
Amyotrophic Lateral Sclerosis (ALS) is a mid-life onset neurodegenerative disease that manifests its symptomatology with motor impairments and cognitive deficits overlapping with Frontotemporal Lobar Degeneration (FTLD). The etiology of ALS remains elusive, with various mechanisms and cellular targe...
Autores principales: | Poulin-Brière, Amélie, Rezaei, Edris, Pozzi, Silvia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667723/ https://www.ncbi.nlm.nih.gov/pubmed/34912191 http://dx.doi.org/10.3389/fnins.2021.790114 |
Ejemplares similares
-
Protein Homeostasis in Amyotrophic Lateral Sclerosis: Therapeutic Opportunities?
por: Webster, Christopher P., et al.
Publicado: (2017) -
Neuroimmunity dynamics and the development of therapeutic strategies for amyotrophic lateral sclerosis
por: Bowerman, Melissa, et al.
Publicado: (2013) -
Therapeutic Approaches Targeting Protein Aggregation in Amyotrophic Lateral Sclerosis
por: Malik, Ravinder, et al.
Publicado: (2020) -
Therapeutic Targeting of Proteostasis in Amyotrophic Lateral Sclerosis—a Systematic Review and Meta-Analysis of Preclinical Research
por: Elliott, Elizabeth, et al.
Publicado: (2020) -
NEK1 Variants in a Cohort of Italian Patients With Amyotrophic Lateral Sclerosis
por: Riva, Nilo, et al.
Publicado: (2022)